Dr. Brenner is a molecular cancer epidemiologist in the Department of Cancer Epidemiology and Prevention Research. His research is focused on the intersection of lifestyle, genetics and molecular pathways in the development of several cancers, including lung, breast and colon. The impact of chronic inflammation from lifestyle (obesity, physical inactivity, smoking, poor nutrition) and environmental factors on breast and lung cancer risk are currently being evaluated in several case-control, cohort and randomized intervention trials. The aim of this research is to identify high risk populations, novel risk factor profiles and potential markers of early detection of cancer.
Dr. Brockton studies the effects of lifestyle, diet, and genetics on the inflammation implicated in the development and progression of breast, colorectal and head and neck cancers. His current research programs include the study of hypoxic signaling in head and neck cancer, and the anti-inflammatory role of vitamin D in cancer progression.
Dr. Friedenreich focuses her research program primarily on the role of physical activity in cancer control. She has developed both a lifetime and a past-year physical activity questionnaire for use in her research studies. She is the also the Principal Investigator of several large population-based case-control and cohort studies, as well as several randomized controlled intervention trials of exercise for cancer prevention, rehabilitation and survival. Dr. Friedenreich is an AI-HS Health Senior Scholar, and holds the Alberta Cancer Foundation Weekend to End Women’s Cancers Breast Cancer Chair.
Dr. Kopciuk’s research involves developing innovative study designs and statistical methods for genetic epidemiology and studies utilizing data from high-throughput platforms. She is a trans-disciplinary researcher who is a member of several research teams investigating diseases to identify markers of disease, including several that have a genetic basis.